Teixeira et al. [60] reviewed the association of increased blood levels of eotaxin-1/CCL11 in patients with major psychiatric disorders including schizophrenia, major depression, bipolar disease, autism spectrum disorder, dysthymia, and Alzheimer’s disease. Here, CCL11 is linked to schizophrenia.